Eagle Capital Management MDLN trades
Ravenel Boykin Curry IV
Eagle Capital Management Medline Inc, CL-A stake
total: 185
Trades details
- Total transactions:
- 1
- New positions:
- 1
- Held for:
- 0 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Eagle Capital Management holds 5,187,088 Medline Inc, CL-A (MDLN) shares with a market value of roughly $179.99M accounting for 0.55% of the overall portfolio. Eagle Capital Management first purchased MDLN in 2026 Q3, initially acquiring about 5.19M shares.
When did Eagle Capital Management buy Medline Inc, CL-A (MDLN)?
Eagle Capital Management first invested in Medline Inc, CL-A (MDLN) in 2026 Q3 at the reported quarter-end price of $34.70 per share.
Eagle Capital Management's historical trades in Medline Inc, CL-A
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.55%
|
5,187,088
|
$34.70
|
$179,991,953
|
new
|
+0.55%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.